• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2009-2014 年丹麦肺结核治疗结局的预测因素。

Predictors for Pulmonary Tuberculosis Treatment Outcome in Denmark 2009-2014.

机构信息

Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.

Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

出版信息

Sci Rep. 2019 Sep 10;9(1):12995. doi: 10.1038/s41598-019-49439-9.

DOI:10.1038/s41598-019-49439-9
PMID:31506499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6736960/
Abstract

Monitoring of tuberculosis (TB) treatment outcome is essential to ensure an effective TB control program. In this nationwide retrospective cohort study from Denmark we present TB treatment outcome rates and risk factors associated with an unfavourable outcome. All patients notified with pulmonary TB from 2009 through 2014 were included. Logistic regression analyses were used to identify risk factors for unfavourable outcome. In total, 1681 pulmonary TB cases were included. TB treatment success rates increased during the study period. In 2014, the treatment success rate reached 85% for new culture positive cases whereas 7% cases interrupted treatment. The mortality decreased during the study period from 12.3% to 4.1%. Several risk factors associated with unfavourable outcome were identified in a multivariable model: male (OR: 2.56), Greenlandic origin (OR: 1.80), abuse of alcohol (OR: 2.90), history of mental disorder (OR: 2.46), and anaemia at time of treatment initiation (OR: 1.92). In a TB low incidence setting such as the Danish, it is important to maintain focus on preventing an unfavourable TB outcome. Patient management and treatment can be optimized by taking into consideration risk factors such as those identified in the present study.

摘要

监测结核病(TB)治疗结果对于确保有效的结核病控制计划至关重要。在这项来自丹麦的全国性回顾性队列研究中,我们介绍了结核病治疗结果率和与不良结果相关的危险因素。所有 2009 年至 2014 年期间经通知患有肺结核的患者均被纳入研究。我们使用逻辑回归分析来确定不良结果的危险因素。共有 1681 例肺结核病例被纳入研究。在研究期间,结核病治疗成功率有所提高。2014 年,新的培养阳性病例的治疗成功率达到 85%,而中断治疗的病例占 7%。在研究期间,死亡率从 12.3%下降至 4.1%。在多变量模型中确定了与不良结果相关的几个危险因素:男性(OR:2.56)、格陵兰血统(OR:1.80)、酗酒(OR:2.90)、精神障碍史(OR:2.46)和治疗开始时贫血(OR:1.92)。在丹麦这样结核病发病率较低的环境中,重要的是要继续关注预防不良的结核病结果。通过考虑本研究中确定的危险因素,可以优化患者管理和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/6736960/6c9c5901dd88/41598_2019_49439_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/6736960/eac69addba4e/41598_2019_49439_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/6736960/6c9c5901dd88/41598_2019_49439_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/6736960/eac69addba4e/41598_2019_49439_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18fc/6736960/6c9c5901dd88/41598_2019_49439_Fig2_HTML.jpg

相似文献

1
Predictors for Pulmonary Tuberculosis Treatment Outcome in Denmark 2009-2014.2009-2014 年丹麦肺结核治疗结局的预测因素。
Sci Rep. 2019 Sep 10;9(1):12995. doi: 10.1038/s41598-019-49439-9.
2
Treatment outcome of new culture positive pulmonary tuberculosis in Norway.挪威新确诊的痰菌阳性肺结核的治疗结果
BMC Public Health. 2005 Feb 7;5:14. doi: 10.1186/1471-2458-5-14.
3
Predictors and mortality associated with treatment default in pulmonary tuberculosis.与肺结核治疗中断相关的预测因素和死亡率。
Int J Tuberc Lung Dis. 2010 Apr;14(4):454-63.
4
Treatment outcome of new pulmonary tuberculosis in Guangzhou, China 1993-2002: a register-based cohort study.1993 - 2002年中国广州新发肺结核的治疗结果:一项基于登记的队列研究。
BMC Public Health. 2007 Nov 29;7:344. doi: 10.1186/1471-2458-7-344.
5
[Tuberculosis in Romania between 2006-2008].[2006 - 2008年罗马尼亚的结核病情况]
Pneumologia. 2009 Jan-Mar;58(1):29-38.
6
Characteristics and predictors for tuberculosis related mortality in Denmark from 2009 through 2014: A retrospective cohort study.2009 年至 2014 年丹麦结核相关死亡的特征和预测因素:一项回顾性队列研究。
PLoS One. 2020 Jun 4;15(6):e0231821. doi: 10.1371/journal.pone.0231821. eCollection 2020.
7
Multidrug-resistant tuberculosis in South Korea: a retrospective analysis of national registry data in 2011-2015.韩国的耐多药结核病:2011-2015 年国家登记数据的回顾性分析。
Int J Tuberc Lung Dis. 2019 Jul 1;23(7):850-857. doi: 10.5588/ijtld.18.0658.
8
Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002-2011.欧洲联盟和欧洲经济区的结核病治疗结果:2002-2011 年监测数据的分析。
Euro Surveill. 2015;20(49). doi: 10.2807/1560-7917.ES.2015.20.49.30087.
9
Multidrug and extensively drug-resistant tuberculosis in Canada 1997-2008: demographic and disease characteristics.1997-2008 年加拿大耐多药和广泛耐药结核病:人口统计学和疾病特征。
PLoS One. 2013;8(1):e53466. doi: 10.1371/journal.pone.0053466. Epub 2013 Jan 9.
10
Burden of multidrug-resistant tuberculosis in England: a focus on prevalent cases.英格兰耐多药结核病负担:以现患病例为重点。
Int J Tuberc Lung Dis. 2019 Jun 1;23(6):707-713. doi: 10.5588/ijtld.18.0399.

引用本文的文献

1
Treatment outcome and associated factors among adult patients with pulmonary tuberculosis in selected health centers in Addis Ababa Ethiopia.埃塞俄比亚亚的斯亚贝巴选定卫生中心成人肺结核患者的治疗结果及其相关因素。
PLoS One. 2023 Oct 5;18(10):e0292218. doi: 10.1371/journal.pone.0292218. eCollection 2023.
2
Evaluation of drug-resistant tuberculosis treatment outcome in Limpopo province, South Africa.南非林波波省耐药结核病治疗结局评价。
Afr J Prim Health Care Fam Med. 2023 Jul 31;15(1):e1-e7. doi: 10.4102/phcfm.v15i1.3764.
3
Factors affecting successful antituberculosis treatment: a single-center experience.

本文引用的文献

1
Underreporting of patients diagnosed with tuberculosis in the Region of Southern Denmark.丹麦南部地区结核病患者漏报情况。
Scand J Public Health. 2020 Dec;48(8):870-876. doi: 10.1177/1403494819884433. Epub 2019 Nov 25.
2
Trends and differences in tuberculosis incidences and clustering among natives in Denmark, Sweden and Finland: comparison of native incidences and molecular epidemiology among three low-incidence countries.丹麦、瑞典和芬兰本国人结核病发病率及聚集性的趋势和差异:三个低发病率国家本国人发病率和分子流行病学的比较。
Clin Microbiol Infect. 2018 Jul;24(7):717-723. doi: 10.1016/j.cmi.2017.10.005. Epub 2017 Oct 12.
3
影响抗结核治疗成功的因素:单中心经验。
Rev Assoc Med Bras (1992). 2023 Apr 14;69(4):e20221054. doi: 10.1590/1806-9282.20221054. eCollection 2023.
4
Contributory Factors to Successful Tuberculosis Treatment in Southwest Nigeria: A Cross-Sectional Study.尼日利亚西南部结核病治疗成功的促成因素:一项横断面研究。
Trop Med Infect Dis. 2022 Aug 19;7(8):194. doi: 10.3390/tropicalmed7080194.
5
A new blood-based RNA signature (R), for monitoring effectiveness of tuberculosis treatment in a South Indian longitudinal cohort.一种基于血液的新型RNA特征(R),用于监测印度南部一个纵向队列中结核病治疗的有效性。
iScience. 2022 Jan 10;25(2):103745. doi: 10.1016/j.isci.2022.103745. eCollection 2022 Feb 18.
6
The prevalence of diabetes among tuberculosis patients in Denmark.丹麦结核病患者中的糖尿病患病率。
BMC Infect Dis. 2022 Jan 19;22(1):64. doi: 10.1186/s12879-022-07048-4.
7
Pharmacodynamic biomarkers for quantifying the mycobacterial effect of high doses of rifampin in patients with rifampin-susceptible pulmonary tuberculosis.用于量化高剂量利福平在利福平敏感肺结核患者中对分枝杆菌作用的药效学生物标志物。
Int J Mycobacteriol. 2021 Oct-Dec;10(4):457-462. doi: 10.4103/ijmy.ijmy_178_21.
8
Community health workers augment the cascade of TB detection to care in urban slums of two metro cities in India.社区卫生工作者在印度两个大都市的城市贫民窟中加强了结核病检测到护理的级联。
J Glob Health. 2021 Jul 17;11:04042. doi: 10.7189/jogh.11.04042. eCollection 2021.
9
The trend of tuberculosis case notification and predictors of unsuccessful treatment outcomes in Samdrup Jongkhar district, Bhutan: A fourteen-year retrospective study.不丹萨姆德鲁琼卡尔地区结核病病例通报趋势及治疗结果未成功的预测因素:一项十四年回顾性研究
Heliyon. 2021 Mar 25;7(3):e06573. doi: 10.1016/j.heliyon.2021.e06573. eCollection 2021 Mar.
10
Anemia in tuberculosis cases: A biomarker of severity?结核病患者的贫血:严重程度的生物标志物?
PLoS One. 2021 Feb 2;16(2):e0245458. doi: 10.1371/journal.pone.0245458. eCollection 2021.
Role of Anaemia and Magnesium Levels at the Initiation of Tuberculosis Therapy with Sputum Conversion among Pulmonary Tuberculosis Patients.
肺结核患者开始抗结核治疗时贫血和镁水平对痰菌转阴的作用
J Clin Diagn Res. 2017 Jun;11(6):BC01-BC04. doi: 10.7860/JCDR/2017/23734.9975. Epub 2017 Jun 1.
4
Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.欧洲的结核病治疗结果:基于治疗完成情况,而非治愈情况。
Am J Respir Crit Care Med. 2017 Nov 1;196(9):1222-1224. doi: 10.1164/rccm.201612-2585LE.
5
Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002-2011.欧洲联盟和欧洲经济区的结核病治疗结果:2002-2011 年监测数据的分析。
Euro Surveill. 2015;20(49). doi: 10.2807/1560-7917.ES.2015.20.49.30087.
6
The Danish National Patient Registry: a review of content, data quality, and research potential.丹麦国家患者登记处:内容、数据质量及研究潜力综述
Clin Epidemiol. 2015 Nov 17;7:449-90. doi: 10.2147/CLEP.S91125. eCollection 2015.
7
Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.耐多药结核病治疗期间获得的广泛耐药
Clin Infect Dis. 2014 Oct 15;59(8):1049-63. doi: 10.1093/cid/ciu572. Epub 2014 Jul 23.
8
Mycobacterium tuberculosis outbreak strain of Danish origin spreading at worrying rates among greenland-born persons in Denmark and Greenland.源自丹麦的结核分枝杆菌暴发菌株正在丹麦和格陵兰岛出生的人群中以令人担忧的速度传播。
J Clin Microbiol. 2013 Dec;51(12):4040-4. doi: 10.1128/JCM.01916-13. Epub 2013 Sep 25.
9
Treatment outcome monitoring of pulmonary tuberculosis cases notified in France in 2009.2009 年法国报告肺结核病例的治疗效果监测。
Euro Surveill. 2013 Mar 21;18(12):20434.
10
Iron deficiency and anemia predict mortality in patients with tuberculosis.缺铁和贫血可预测结核病患者的死亡率。
J Nutr. 2012 Feb;142(2):350-7. doi: 10.3945/jn.111.144287. Epub 2011 Dec 21.